The identification of therapeutic agents that can prevent the pancreatic injury after endoscopic retrograde cholangiopancreatography (ERCP) is of considerable importance.
|Number of pages||7|
|Publication status||Published - 2000|
- Acute Disease
- Cholangiopancreatography, Endoscopic Retrograde
- Serine Proteinase Inhibitors
- Treatment Outcome